Trials / Completed
CompletedNCT03306914
Comparing Human Albumin Versus Hydroxyethylstarch in Renal Transplant Recipients
Plasma Volume Expansion for Optimum Renal Transplant Surgery: Albumin Versus Starch
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Cairo University · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
In this study we try to review the possible effects when using modern hydroxyethylstarch solutions 6 % versus albumin 5% during living donor renal transplantation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Albumin resuscitation | Albumin 5% is used as the intra-operative colloid |
| OTHER | Hydroxyethylstarch resuscitation | Hydroxyethyl starch 6% is used as the intra-operative colloid |
| DRUG | Albumin 5% | Infusion of Albumin 5% intra-operatively |
| DRUG | Hydroxyethylstarch 6% | Infusion of Hydroxyethylstarch 6% intra-operatively |
Timeline
- Start date
- 2017-10-15
- Primary completion
- 2019-02-01
- Completion
- 2019-02-01
- First posted
- 2017-10-11
- Last updated
- 2020-01-28
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03306914. Inclusion in this directory is not an endorsement.